Cyclerion Therapeutics Inc (CYCN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 875 | 93 | 81 | 1,806 | 194 |
| Gross Profit | 875 | 93 | 81 | 1,806 | 194 |
| Operating Expenses | 1,881 | 1,765 | 1,538 | 1,304 | 1,322 |
| Operating Income | -1,006 | -1,672 | -1,457 | 502 | -1,128 |
| Other Income | 30 | 1,348 | 28 | 28 | 405 |
| Pre-tax Income | -976 | -324 | -1,429 | 530 | -723 |
| Net Income Continuous | -976 | -324 | -1,429 | 530 | -723 |
| Net Income | $-976 | $-324 | $-1,429 | $530 | $-723 |
| EPS Basic Total Ops | -0.30 | -0.11 | -0.56 | 0.23 | -0.29 |
| EPS Basic Continuous Ops | -0.30 | -0.11 | -0.56 | 0.22 | -0.29 |
| EPS Diluted Total Ops | -0.30 | -0.11 | -0.56 | 0.23 | -0.29 |
| EPS Diluted Continuous Ops | -0.30 | -0.11 | -0.56 | 0.22 | -0.29 |
| EPS Diluted Before Non-Recurring Items | -0.30 | -0.11 | -0.56 | 0.22 | -0.29 |
| EBITDA(a) | $-1,006 | $-1,672 | $-1,457 | $502 | $-1,128 |